NervGen Pharma Corp. Common stock

NGEN

Healthcare|Biotechnology|CA

$1.33

+0.01 (+0.76%)

DCF Value

$0.17

Tangible Book / Share

$0.18

Cash / Share

$0.94

Clinical Trials (0)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug